LOGSX Performance — Live Oak Health Sciences Fund

Data updated: 2026-09-29

LOGSX returned +8.33% year to date and +29.34% over one year to Jul 2026. Annualised returns are +10.82% over 3 years and +6.90% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $136, against $137 for the category, and to $129 over one year, against $137. Volatility over the past three years was 12.52% a year. In the 12 months to Jul 2026 the fund lost a net $2.8M, and assets reached $56.13M.

LOGSX Growth of $100

What $100 invested in Live Oak Health Sciences Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.

PeriodLOGSXCategory average
1 year (Aug 2025 – Jul 2026)$129$137
3 years (Aug 2023 – Jul 2026)$136$137
5 years (Aug 2021 – Jul 2026)$140$121
Since data start (Aug 2019 – Jul 2026)$176$183

LOGSX Trailing Returns

Total returns to Jul 2026, from SEC N-PORT.

PeriodTotal return
YTD+8.33%
1 year+29.34%
3 years (annualised)+10.82%
5 years (annualised)+6.90%

LOGSX Annual Returns

Calendar-year total returns of Live Oak Health Sciences Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jul)+8.33%
2025+19.63%
2024+0.17%
2023+1.19%
2022+3.72%
2021+17.51%
2020+10.05%
2019 (Aug–Dec)+0.14%

LOGSX Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+1.9%+3.6%−5.0%−1.6%+1.0%+6.0%+2.5%—————
2025+6.0%−0.1%−1.5%−0.8%−1.1%+1.9%−3.9%+3.5%+3.1%+4.3%+9.4%−1.9%
2024+2.3%+0.8%+1.9%−5.3%+2.6%+1.7%+5.2%+3.4%−3.7%−3.3%+2.0%−6.8%
2023−1.5%−5.4%+1.4%+2.3%−5.0%+4.2%+0.7%−0.5%−1.2%−2.3%+5.3%+3.7%
2022−5.0%−0.8%+6.1%−3.1%+1.4%−3.3%+3.6%−3.5%−3.7%+11.5%+3.6%−1.9%
2021+1.0%−1.1%+5.2%+4.7%−0.1%+2.0%+2.2%+1.2%−5.3%+4.9%−6.9%+9.5%
20200.0%0.0%0.0%+0.1%+4.5%−3.7%+1.7%+1.5%−2.3%−3.9%+8.5%+4.1%
2019———————0.0%0.0%+0.1%+0.1%0.0%

LOGSX Risk

Risk measures from monthly returns over Aug 2023 – Jul 2026.

  • 3-year volatility (annualised): 12.52%
  • 3-year Sharpe ratio: 0.50 (vs 4.5% risk-free rate)
  • Best month: +9.38% (Nov 2025)
  • Worst month: −6.85% (Dec 2024)

LOGSX Fund Flows

Monthly money in and out of Live Oak Health Sciences Fund, from SEC Form N-PORT.

  • 12-month net flow: −$2.8M
  • 12-month gross sales (incl. reinvestments): $7.6M
  • Sales ÷ redemptions: 0.73×
MonthSalesRedemptionsNet flow
Jul 2026$3.0M$912K$2.1M
Jun 2026$458K$113K$345K
May 2026$221K$857K−$636K
Apr 2026$402K$388K$14K
Mar 2026$567K$235K$332K
Feb 2026$333K$2.3M−$1.9M
Jan 2026$229K$1.1M−$867K
Dec 2025$1.3M$235K$1.0M
Nov 2025$321K$3.0M−$2.7M
Oct 2025$453K$585K−$132K
Sep 2025$214K$238K−$24K
Aug 2025$108K$549K−$441K

LOGSX Assets Under Management

Net assets of Live Oak Health Sciences Fund by report date, from SEC N-PORT filings.

Report dateNet assets
2026-07-31$56.13M
2026-04-30$49.52M
2026-01-31$52.61M
2025-10-31$51.56M
2025-07-31$46.92M
2025-04-30$49.45M
2025-01-31$51.59M
2024-10-31$52.52M
2024-07-31$55.30M
2024-04-30$50.87M
2024-01-31$53.37M
2023-10-31$50.15M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.